Loading...

Purified anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_Purified_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and purified N418 (top) or purified Armenian hamster IgG isotype control (bottom), followed by anti-Armenian hamster IgG FITC
  • N418_A_Purified_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and purified N418 (top) or purified Armenian hamster IgG isotype control (bottom), followed by anti-Armenian hamster IgG FITC
  • N418_B_Purified_Neg_071006.jpg
Cat # Size Price Quantity Check Availability Save
117301 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117302 500 µg 113€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF® - Verified
IP, IHC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Molica F,et al. 2017. Sci Rep.. 10.1038/s41598-017-14130-4. PubMed
  2. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  3. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  4. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  5. Oyarce K, et al. 2018. Front Immunol. 9:112. PubMed
  6. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  7. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  8. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  9. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  10. Fu H, et al. 2019. Front Immunol. 10:271. PubMed
  11. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  12. Zhang Z, et al. 2018. Nat Med. 24:617. PubMed
  13. Hung LY, et al. 2019. J Immunol. 203:511. PubMed
  14. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  15. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  16. Goltsev Y et al. 2018. Cell. 174(4):968-981 . PubMed
  17. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  18. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  19. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  20. Kitai Y, et al. 2017. J Immunol. 198:1649. PubMed
  21. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  22. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  23. Rios–Doria J, et al. 2017. Cancer Res. 77:2686. PubMed
  24. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  25. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  26. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  27. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  28. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  29. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  30. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  31. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  32. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  33. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  34. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  35. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  36. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  37. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  38. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  39. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  40. Bonnefoy F, et al. 2018. Front Immunol. 2.170833333. PubMed
  41. Dubrot J, et al. 2018. Life Sci Alliance. 1:e201800164. PubMed
  42. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  43. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  44. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  45. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  46. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  47. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  48. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  49. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  50. von Roemeling CA, et al. 2020. Nat Commun. 11:1508. PubMed
  51. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  52. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  53. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  54. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  55. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  56. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
  57. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  58. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  59. Trittel S, et al. 2019. Sci Rep. 9:16362. PubMed
  60. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  61. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  62. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  63. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  64. Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
  65. Sun L, et al. 2020. Nat Commun. 2.229166667. PubMed
  66. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  67. Majer O, et al. 2019. Nature. 575:366. PubMed
  68. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  69. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  70. Wikstrom M, et al. 2006. J Immunol. 177:913. PubMed
  71. Benson M, et al. 2007. J Exp Med. 204:1765. PubMed
  72. Pericolini E, et al. 2008. J Leukoc Biol. 83:1286. PubMed
  73. Osterholzer J, et al. 2009. J Immunol. 183:8044. PubMed
  74. Fahlén-Yrlid L, et al. 2009. J Immunol. 183:5032. PubMed
  75. Eisenach P, et al. 2010. J Cell Sci. 123:4182. PubMed
  76. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  77. Leppin K, et al. 2014. Invest Ophthalmol Vis Sci . 55:3603. PubMed
  78. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  79. Aparicio-Domingo P, et al. 2015. J Exp Med. 101084/jm20150318. PubMed
  80. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  81. Cepeda JR, et al. 2020. MAbs. 12:1836714. PubMed
  82. Martinez LE, et al. 2020. J Virol. 94:00:00. PubMed
  83. Tal MC, et al. 2020. MBio. 11:00. PubMed
  84. Mendes A, et al. 2021. Life Sci Alliance. 4:00. PubMed
  85. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  86. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
  87. Blriot C, et al. 2021. Immunity. :. PubMed
  88. García G, et al. 2020. Am J Pathol. 844:190. PubMed
  89. Fang C, et al. 2020. Cell Mol Immunol. . PubMed
  90. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  91. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  92. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  93. Rebouças A, et al. 2021. Microorganisms. 9:. PubMed
  94. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  95. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  96. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  97. Owen KL, et al. 2020. EMBO Rep. 21:e50162. PubMed
  98. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  99. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  100. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  101. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  102. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  103. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  104. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  105. Enders M, et al. 2020. J Immunol. 204:87. PubMed
  106. Rigo MM, et al. 2020. FEBS J. :. PubMed
  107. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  108. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  109. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  110. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  111. Bruce DW, et al. 2021. Blood Adv. 5:4578. PubMed
  112. Chen B, et al. 2021. Cell. 184:6262. PubMed
  113. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  114. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  115. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  116. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  117. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  118. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  119. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  120. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  121. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  122. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  123. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  124. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  125. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  126. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  127. Wang Y, et al. 2021. Sci Transl Med. 13:. PubMed
  128. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  129. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  130. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  131. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  132. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  133. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  134. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  135. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  136. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  137. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  138. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  139. Blériot C, et al. 2020. Methods Mol Biol. 2164:87. PubMed
  140. Cai S, et al. 2020. Sci Rep. 10:14249. PubMed
  141. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  142. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  143. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  144. Liedmann S, et al. 2022. Mol Cell. 82:2401. PubMed
  145. Campisi L, et al. 2022. Nature. 606:945. PubMed
  146. Chi H, et al. 2022. Cells. 11: . PubMed
  147. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  148. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  149. Hezaveh K, et al. 2022. Immunity. 55:324. PubMed
  150. Chen W, et al. 2023. JCI Insight. 8:. PubMed
  151. Iguchi A, et al. 2023. iScience. 26:106375. PubMed
  152. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
RRID
AB_313770 (BioLegend Cat. No. 117301)
AB_313771 (BioLegend Cat. No. 117302)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account